Search results
Mar 25, 2021 · The Bangladeshi company was founded in 1976. Four years later, Beximco Pharmaceuticals started manufacturing products under the licences of Germany-based Bayer and Upjohn of the US, and launched its own formulation brands three years later. In 1985, it was listed on the Dhaka Stock Exchange. Today, Beximco manufactures and markets its own ...
Beximco Pharmaceuticals Ltd. (Beximco Pharma) is an emerging generic drug player committed to providing access to affordable medicines. Company’s state-of-the-art manufacturing facilities have been accredited by the regulatory authorities of USA, Australia, European Union, Canada, and Brazil, among others, and it currently focuses on building presence in many emerging and developed markets ...
Dec 19, 2016 · Sponsors hold a 13.18 percent stake in Beximco Pharmaceuticals, institutions 27.94 percent, foreign investors 37.84 percent and general investors the rest 21.04 percent, according to the DSE data ...
This is Beximco Pharma's eighth Abbreviated New Drug Application (ANDA) successfully approved for the US market since the Company's oral solid dosage facility was approved by the US FDA in June 2015. The Company expects to launch the product through its US distribution partner in due course. Flecainide Acetate is the generic equivalent to 3M ...
- Local vs International Manufacturing
- Technology Transfer
- 1976 to The Present
- Environmental Concerns
Beximco's main manufacturing site is spread across a 22-acre area located near Dhaka, Bangladesh’s capital city. To build a better picture of the local manufacturing landscape Beximco works with, Reza explains that though companies in Bangladesh are producing large quantities of molecules, the actual number of products coming out of the country is ...
BEXIMCO BY THE NUMBERS: –15 million canisters of metered-dose inhalers per annum –36 million units of dry powder inhaler per annum –37 million units of liquid dosage per annum –6 million units of creams and ointments per annum –10 million units of suppositories per annum –5 billion tablets on a single shift It is interesting to consider the lack of...
Incorporated more than 40 years ago in 1976, the journey the company has taken is important to understanding how it got to where it is today. The pharmaceutical company operates within a larger organisation, but a Group is not a legal entity in Bangladesh. This means that the many branches of Beximco have little to do with one another, and mostly j...
One of the biggest future concerns for pharmaceutical companies across emerging and developed markets is sustainability; both financial and environmental. Commenting on Beximco's eco-friendly initiative, Reza says that the UN actually shows Beximco as an example in third world countries for how it cares for the environment. He talks about the compa...
BEXIMCO. Bangladesh Export Import Company Limited (Bangla transliteration: বাংলাদেশ এক্সপোর্ট ইমপোর্ট কোম্পানি লিমিটেড), commonly known by its trade name BEXIMCO (Bangla: বেক্সিমকো) (DSE: BEXIMCO CSE: BEXIMCO), is a Bangladeshi multinational ...
People also ask
Does Beximco support foreign partners?
Is Beximco a US drug company?
When was Beximco founded?
Who is Beximco Pharmaceuticals Ltd (BPL)?
Where is Beximco Pharma made?
What makes Beximco Pharma unique?
Its first foray into foreign markets occurred in 1993, when it began selling to Russia. At the time, it was a highly speculative gamble. Mr Hassan explains that the company was interested in the post-Soviet market and believed that the collapse of the Communist government there would create a huge demand for healthcare and pharmaceuticals.
